Research

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

High school researchers at VUMC glimpse the future

They were part of the Aspirnaut program, which prepares high school and college students, primarily from rural areas, for careers in the STEM fields.

A fast daily walk could extend your life: study

Just 15 minutes per day of fast walking reduced the risk of premature death in a low-income and predominantly Black U.S. population.

Large-scale study uncovers 57 genetic hotspots into stuttering origins

The video is produced by the research team to explain the results of the study. Findings from the largest genetic analysis of stuttering are published in Nature Genetics; they point to 48 genes associated with stuttering and highlight neurological pathways of risk.

Ravi Shah named to co-direct Vanderbilt Diabetes Center

The Center oversees the NIH-funded Diabetes Research and Training Center, now in its 52nd year of continual operation, which advances innovative investigations related to the cause, prevention, treatment and complications of diabetes and obesity.

Joshua Carty, MD

VUMC nephrology fellow Joshua Carty wins grant to study rare kidney disorder

Carty’s research focuses on nephrogenic diabetes insipidus, a rare kidney condition in which the body produces too much urine, leading to potentially dangerous dehydration.

1 5 6 7 8 9 137